当前蛋白身份:P02760 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1BIK X-RAY STRUCTURE OF BIKUNIN FROM THE HUMAN INTER-ALPHA-INHIBITOR COMPLEX 提交 1997-11-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 206–352(147 aa) 片段:DOMAIN II,78 - 133
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.5;pH 7.5
分辨率 2.50 Å R-free 0.253
3QKG Crystal structure of alpha-1-microglobulin at 2.3 A resolution 提交 2011-02-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 20–202(183 aa) 片段:lipocalin
突变:C34S NI NICKEL (II) ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;100 mM Tris-HCl, 1.1 M sodium citrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.30 Å R-free 0.260
4ES7 crystal structure of protein HC from Homo sapiens at 2 angstrom 提交 2012-04-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 27–193(167 aa) 片段:UNP residues 27-193
未记录 PEG DI(HYDROXYETHYL)ETHER × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.9;293 K;0.2M ammonium citrate, 20% PEG 3350, 0.1M HEPES pH 6.9, 40% 1,1,1,3,3,3-Hexafluoro-z-propanol, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.00 Å R-free 0.261
4U30 Human mesotrypsin complexed with bikunin Kunitz domain 2 提交 2014-07-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 X 283–340(58 aa) 片段:BPTI/Kunitz inhibitor 2 residues 285-338
未记录 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;0.1 M HEPES pH 7.0 and 1 M sodium citrate
分辨率 2.50 Å R-free 0.223
4U30 Human mesotrypsin complexed with bikunin Kunitz domain 2 提交 2014-07-18 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 Z 283–340(58 aa) 片段:BPTI/Kunitz inhibitor 2 residues 285-338
未记录 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;0.1 M HEPES pH 7.0 and 1 M sodium citrate
分辨率 2.50 Å R-free 0.223
4U30 Human mesotrypsin complexed with bikunin Kunitz domain 2 提交 2014-07-18 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 W 283–340(58 aa) 片段:BPTI/Kunitz inhibitor 2 residues 285-338
未记录 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;0.1 M HEPES pH 7.0 and 1 M sodium citrate
分辨率 2.50 Å R-free 0.223
4U30 Human mesotrypsin complexed with bikunin Kunitz domain 2 提交 2014-07-18 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 Y 283–340(58 aa) 片段:BPTI/Kunitz inhibitor 2 residues 285-338
未记录 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;0.1 M HEPES pH 7.0 and 1 M sodium citrate
分辨率 2.50 Å R-free 0.223
6EJ7 Human Xylosyltransferase 1 in complex with UDP-xylose and peptide QEEEGAGGGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa)
突变:S215A, L220G, V221G NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 UDX URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE × 1 NA SODIUM ION × 1 PO4 PHOSPHATE ION × 9 EDO 1,2-ETHANEDIOL × 4 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus precipitant mix 2 (PEG8000 and ethylene glycol), 0.1M Bicine/Tris buffer at pH 7.5 0.1 M of Morpheus NPS mix.
分辨率 2.00 Å R-free 0.230
6EJ8 Human Xylosyltransferase 1 in complex with peptide QEEEGSGGGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa)
突变:L220G, V221G NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 NA SODIUM ION × 1 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 2.09 Å R-free 0.223
6EJ9 Human Xylosyltransferase 1 in complex with peptide QEPEGSGGGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–220(11 aa)
突变:E212P, L220G, V221G PO4 PHOSPHATE ION × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 2.02 Å R-free 0.225
6EJA Human Xylosyltransferase 1 in complex with peptide QEEEYSGGGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa) 片段:UNP residues 210-221
突变:G214Y, L220G, V221G NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 1.94 Å R-free 0.212
6EJB Human Xylosyltransferase 1 in complex with peptide QEEEGSAGGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa)
突变:G216A, L220G, V221G PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 2.56 Å R-free 0.280
6EJC Human Xylosyltransferase 1 in complex with peptide QEEEGSGVGQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa) 片段:UNP residues 210-221
突变:G217V, L220G, V221G PO4 PHOSPHATE ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 2.06 Å R-free 0.273
6EJD Human Xylosyltransferase 1 in complex with peptide QEEEGSGGPQGG 提交 2017-09-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 210–221(12 aa) 片段:UNP residues 210-221
突变:G218P, L220G, V221G PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;55-65% Morpheus Precipitant mix 2 (PEG8000 and Ethylene glycol) 0.1M Bicine/Tris buffer at pH 7.5 0.1M of NPS mix (0.033M of each)
分辨率 2.68 Å R-free 0.279